Blog

Home » Blog

Lawson Health scientists capture prostate cancer images using unique molecule

Technology / By / / 1 minute of reading

Scientists at Lawson Health Research Institute in London are the first in Canada to capture prostate cancer images using a new molecule. Known as a Prostate Specific Membrane Antigen (PSMA) probe, the new molecule is used in Positron Emissions Tomography (PET) scans. The probe targets PSMA, a unique molecule on prostate cancer cells, to provide highly specific images for better diagnosis and management of patient disease. Read the article here.

Lawson Health scientists capture prostate cancer images using unique molecule Read More »

Video: A Surgeon and His Patient

Videos, Awareness Nights, Radical Prostatectomy / By / / 1 minute of reading

September 2016 Awareness Night A Surgeon and His Patient – A Patient and His Surgeon Mark Cullen, Gardening Expert Radio and Television Personality and Best-selling Author Well-known newspaper and magazine columnist Member of the Order of Canada Prostate Cancer Survivor DR. GROLL’S PATIENT   Dr. Ryan Groll, MD, MSc, FRCPC Endourologist, Laparoscopic and Robotic Surgeon Michael Garron Hospital (Toronto East Health Network) (formerly Toronto East York General Hospital) Lectuter, Dept. of Surgery, U. of Toronto MARK CULLEN’S SURGEON   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 52:22 minutes

Video: A Surgeon and His Patient Read More »

Newsletter October 2016

Newsletters / By / / 1 minute of reading

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Sept. Awareness Night:  Mark Cullen and Dr. Ryan Groll: A patient and his surgeon July Awareness Night:  Dr. Massom Haider: the important role of the MRI Meet our newest boarf member: Ari Katz Jim Moran (1942-2016) Coming Nov. Awareness Night: Dr. Andrew Matthew: Sexual Health and Prostate Cancer Report on the recent BC Support Group Conference Stepping Down by Chairman Winston Klass Ask the Doctor: Dr. Sharon Sharir – Making the best of your doctor appointments 2016 Cruisin’ for a Cure Board News The Nov.

Newsletter October 2016 Read More »

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Active Surveillance, Radiation, Radical Prostatectomy / By / / 1 minute of reading

This New England Journal of Medicine article gives  the results of a randomized trial of 3 possible prostate cancer treatments.  It is rather long and academic, but shows similar results for the 3 options. Read the article here.

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer Read More »

Revolutionary new cancer treatment makes patients SIX TIMES more likely to survive

Genetics / By / / 1 minute of reading

A revolutionary new DNA treatment technique involves having a simple DNA test of your tumour first. This then tells doctors precisely which drugs or therapies are most suited to you – rather than relying on the standard treatment. The genetic profiling of your tumour can also tell doctors which drugs you should avoid because they either won’t help you or are likely to give you worse side effects than others might suffer. Read the article.

Revolutionary new cancer treatment makes patients SIX TIMES more likely to survive Read More »

Prostate cancer: Four extra inches on a man’s waistline increases deadly disease risk by a fifth

Diet, Exercise / By / / 1 minute of reading

A 14-year-study, which spanned eight countries, found that overall, an extra four inches on the waist was associated with a 13 per cent increased risk of prostate cancer – and an 18 per cent rise in fatal disease. Read the article.

Prostate cancer: Four extra inches on a man’s waistline increases deadly disease risk by a fifth Read More »

Clinical trial will test use of MRI to improve prostate cancer diagnosis and management

Clinical Trials / By / / 1 minute of reading

The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer. The primary objective is to determine whether MRI imaging can spare some men from undergoing a biopsy and avoid the possible associated side effects. The trial will be led by Dr. Laurence Klotz of the Sunnybrook Research Institute in Toronto. Read the article.

Clinical trial will test use of MRI to improve prostate cancer diagnosis and management Read More »

Scroll to Top